[Translation] A randomized, double-blind, single-center, placebo-controlled, dose-escalating Phase Ia trial to evaluate the safety, tolerability and pharmacokinetics of DBM-1152A inhalation solution administered as a single dose to healthy Chinese subjects. Research
(1) 考察DBM-1152A吸入溶液单次吸入给药在中国健康受试者体内的安全性和耐受性;
(2) 考察DBM-1152A吸入溶液单次吸入给药在中国健康受试者体内的药代动力学特征;
(3) 探索性评估中国健康受试者使用DBM-1152A吸入溶液后的C-QTc关系。
[Translation] (1) To investigate the safety and tolerability of a single inhalation administration of DBM-1152A inhalation solution in Chinese healthy subjects;
(2) Examine the pharmacokinetic characteristics of DBM-1152A inhalation solution administered in a single inhalation dose to Chinese healthy subjects;
(3) Exploratory evaluation of the C-QTc relationship after administration of DBM-1152A inhalation solution in Chinese healthy subjects.